Unresolved disorder model. using A ATOM 454 N AGLN 58 36.803 -13.668 31.301 0.50 28.37 N Unresolved disorder model. using A ATOM 455 N BGLN 58 36.801 -13.656 31.340 0.50 27.94 N Unresolved disorder model. using A ATOM 456 CA AGLN 58 37.610 -13.519 30.091 0.50 28.20 C Unresolved disorder model. using A ATOM 457 CA BGLN 58 37.716 -13.509 30.205 0.50 27.20 C Unresolved disorder model. using A ATOM 458 C AGLN 58 38.136 -14.873 29.591 0.50 28.16 C Unresolved disorder model. using A ATOM 459 C BGLN 58 38.061 -14.876 29.628 0.50 27.63 C Unresolved disorder model. using A ATOM 460 O AGLN 58 38.208 -15.090 28.387 0.50 30.17 O Unresolved disorder model. using A ATOM 461 O BGLN 58 37.920 -15.105 28.432 0.50 29.12 O Unresolved disorder model. using A ATOM 462 CB AGLN 58 38.743 -12.501 30.301 0.50 26.88 C Unresolved disorder model. using A ATOM 463 CB BGLN 58 38.997 -12.769 30.634 0.50 26.06 C Unresolved disorder model. using A ATOM 464 CG AGLN 58 38.264 -11.070 30.671 0.50 26.19 C Unresolved disorder model. using A ATOM 465 CG BGLN 58 38.755 -11.316 31.081 0.50 25.18 C Unresolved disorder model. using A ATOM 466 CD AGLN 58 37.299 -10.460 29.647 0.50 23.44 C Unresolved disorder model. using A ATOM 467 CD BGLN 58 39.952 -10.648 31.751 0.50 22.90 C Unresolved disorder model. using A ATOM 468 OE1AGLN 58 37.442 -10.670 28.439 0.50 24.25 O Unresolved disorder model. using A ATOM 469 OE1BGLN 58 40.922 -11.293 32.170 0.50 2.37 O Unresolved disorder model. using A ATOM 470 NE2AGLN 58 36.312 -9.706 30.131 0.50 6.41 N Unresolved disorder model. using A ATOM 471 NE2BGLN 58 39.874 -9.332 31.862 0.50 23.09 N 1